Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - BIOLASE, INC | c07638e10vq.htm |
| EX-32.1 - EXHIBIT 32.1 - BIOLASE, INC | c07638exv32w1.htm |
| EX-10.3 - EXHIBIT 10.3 - BIOLASE, INC | c07638exv10w3.htm |
| EX-10.6 - EXHIBIT 10.6 - BIOLASE, INC | c07638exv10w6.htm |
| EX-10.4 - EXHIBIT 10.4 - BIOLASE, INC | c07638exv10w4.htm |
| EX-10.9 - EXHIBIT 10.9 - BIOLASE, INC | c07638exv10w9.htm |
| EX-10.7 - EXHIBIT 10.7 - BIOLASE, INC | c07638exv10w7.htm |
| EX-10.1 - EXHIBIT 10.1 - BIOLASE, INC | c07638exv10w1.htm |
| EX-31.1 - EXHIBIT 31.1 - BIOLASE, INC | c07638exv31w1.htm |
| EX-10.8 - EXHIBIT 10.8 - BIOLASE, INC | c07638exv10w8.htm |
| EX-10.5 - EXHIBIT 10.5 - BIOLASE, INC | c07638exv10w5.htm |
Exhibit 10.2
HENRY SCHEIN, INC.
August 13, 2010
Mr. David M. Mulder
Chief Executive Officer Biolase
Technology, Inc. 4
Cromwell
Irvine, California 92618
Chief Executive Officer Biolase
Technology, Inc. 4
Cromwell
Irvine, California 92618
Dear Mr. Mulder:
Reference is made to the letter agreement between Henry Schein, Inc. (“HSIC”) and Biolase
Technology, Inc. (“Biolase”), dated as of March 9, 2010 (the “March Letter Agreement”).
Effective on August 17, 2010, Section 4 of the March Letter Agreement is hereby amended by deleting
the reference therein to “60 days advance written notice” and replacing it with “45 days’ advance
written notice.”
Please acknowledge your agreement to the foregoing by executing a counterpart of this letter
agreement.
Sincerely,
HENRY SCHEIN, INC.
| By: | /s/ Brian S. Watson | ||
| Brian S. Watson | |||
| Vice President, Strategic and Business Planning | |||
BIOLASE TECHNOLOGY, INC.
| By: | /s/ David M. Mulder | ||
| David M. Mulder | |||
| Chief Financial Officer | |||